Prevention of inappropriate therapy in implantable defibrillators: A meta-analysis of clinical trials comparing single-chamber and dual-chamber arrhythmia discrimination algorithms☆
Introduction
The implantable cardioverter-defibrillator (ICD) has evolved to standard therapy for the prevention of sudden cardiac death in patients with reduced left ventricular function [1], [2], [3], [4], [5]. Despite the accuracy and effectiveness in the diagnosis and treatment of ventricular tachyarrhythmias, the ICD may also result in excess morbidity [6], [7], [8], [9]. One of the factors is inappropriate therapy for atrial tachyarrhythmias or other events. To avoid inappropriate therapy, several detection enhancements were developed to discriminate between atrial and ventricular tachyarrhythmias. In single-chamber devices, discrimination is based on sudden onset, RR interval stability, and electrogram morphology. Theoretically, dual-chamber ICDs have the opportunity to improve arrhythmia discrimination over single-chamber devices by the addition of atrial information. Some studies which compare single-chamber and dual-chamber devices reported small or even non-existent advantages of dual-chamber arrhythmia discrimination [10], [11], [12]. Recent studies support an actual benefit of dual-chamber devices over single-chamber devices [13], [14], [15]. However, conclusive evidence of improved arrhythmia discrimination by dual-chamber ICDs is still lacking. We performed a systematic review and meta-analysis of controlled studies that compared the performance of dual-chamber and single-chamber arrhythmia discrimination, with the purpose of establishing whether dual-chamber arrhythmia discrimination algorithms reduce inappropriate device therapy.
Section snippets
Search strategy
Controlled clinical trials comparing single-chamber with dual-chamber arrhythmia discrimination algorithms implemented in ICDs were identified. Public domain databases including MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials were searched for all published articles from January 1996 to June 2006 related to arrhythmia discrimination by the ICD. The search was restricted to humans and English language literature. The data limits were chosen because the dual-chamber ICD
Search results
A total of 554 references from all databases were found. A total of 458 potentially relevant reports of clinical trials with implantable defibrillators were screened, and 394 were excluded based on titles and abstracts. For detailed evaluation, full-text versions of the remaining 64 reports were retrieved. Of these, 5 reports of 5 controlled studies were included for this analysis.
Qualitative findings
Our search identified 6 controlled clinical studies comparing dual-chamber with single-chamber arrhythmia
Discussion
This meta-analysis demonstrated a significant reduction in the number of inappropriately treated atrial episodes with dual-chamber arrhythmia discrimination. Pooling controlled studies together, dual-chamber arrhythmia discrimination was associated with a 36% reduction in inappropriately treated episodes as compared with single-chamber arrhythmia discrimination. However, the number of patients who received inappropriate therapy was not affected by dual- or single-chamber arrhythmia
Conclusion
This meta-analysis shows that dual-chamber arrhythmia discrimination significantly reduces the number of inappropriately treated atrial episodes compared to single-chamber devices. However, the amount of patients receiving inappropriate therapy was similar between groups.
Acknowledgement
The authors thank Dr P.A. Friedman and Dr M. Glikson for sharing unpublished results of the Detect SVT Study. We thank Dr D. Bänsch and mr. R. Ocklenburg for giving additional data of the 1 + 1 Trial.
References (23)
- et al.
Prevention of inappropriate therapy in implantable cardioverter-defibrillators: results of a prospective, randomized study of tachyarrhythmia detection algorithms
J Am Coll Cardiol
(2004) - et al.
Randomized controlled study of detection enhancements versus rate-only detection to prevent inappropriate therapy in a dual-chamber implantable cardioverter-defibrillator
Heart Rhythm
(2004) - et al.
Meta-analysis in clinical trials
Control Clin Trials
(1986) - et al.
A randomized comparison of atrial and dual-chamber pacing in 177 consecutive patients with sick sinus syndrome: echocardiographic and clinical outcome
J Am Coll Cardiol
(2003) - et al.
Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators
N Engl J Med
(1996) A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators
N Engl J Med
(1997)- et al.
A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators
N Engl J Med
(1999) - et al.
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction
N Engl J Med
(2002) - et al.
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure
N Engl J Med
(2005) - et al.
Limitations and late complications of third-generation automatic cardioverter-defibrillators
Circulation
(1995)
Adverse events with transvenous implantable cardioverter-defibrillators: a prospective multicenter study. European 7219 Jewel ICD investigators
Circulation
Cited by (68)
Arrhythmic Storm Due to ICD Atrial Lead Malfunction
2022, JACC: Case ReportsCitation Excerpt :However, this potential benefit has not been assessed in randomized clinical trials. Moreover, a meta-analysis showed that the rates of inappropriate ICD shocks were not different between single- and dual-chamber devices.5 In addition, cardiac pacing was historically recommended as a potentially useful preventive strategy in LQTS because it was thought to prevent “pause-dependent” ventricular tachycardia induction.7
Appropriate and inappropriate therapy in patients with single- or multi-chamber implantable cardioverter-defibrillators
2020, Hellenic Journal of CardiologyModern Considerations in ICD Therapy
2017, Encyclopedia of Cardiovascular Research and MedicineIncidence of Device-Detected Atrial Fibrillation and Long-Term Outcomes in Patients With Hypertrophic Cardiomyopathy
2017, American Journal of Cardiology
- ☆
DAMJ Theuns received research grants from Biotronik (Netherlands) and Guidant (Netherlands). DAMJ Theuns is a consultant for Cameron Health (USA). L Jordaens received research grants and speaker fees from Biotronik, Guidant, Medtronic, Sorin, and St Jude Medical.